Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 5, 1998, Pages 1489-1493

  Manau, Dolors ^a   Balasch, Juan ^a,c   Arroyo, Vicente ^b   Jiménez, Wladimiro ^b   Fabregues, Francisco ^a   Casamitjana, Roser ^b   Creus, Montserrat ^a   Vanrell, Juan A ^a  

^a Digestive Diseases Unit   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; ESTROGEN; NITRIC OXIDE;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; ESTROGEN BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HEART OUTPUT; HUMAN; HYPOTENSION; OVARY HYPERSTIMULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RESISTANCE;

ADULT; ALDOSTERONE; BLOOD PRESSURE; CARDIAC OUTPUT; CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HEMODYNAMIC PROCESSES; HUMANS; NOREPINEPHRINE; OVARIAN FOLLICLE; OVARIAN HYPERSTIMULATION SYNDROME; RENIN; VASCULAR RESISTANCE; VASODILATION;

EID: 0031724121     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.5.1489     Document Type: Article

References (36)

1. de Mouzon J, Lancaster P, and the International Working Group for Registers on Assisted Reproduction. 1997 World collaborative report on in vitro fertilization. Preliminary data for 1995. J Assist Reprod Genet. 14:251S-265S.
2. Society for Assisted Reproductive Technology, and the American Society for Reproductive Medicine. 1996 Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 66:697-705.
3. Goĺan A, Ron-El R, Herman A, Soffer Y, Weinraub Z, Caspi E. 1989 Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 44:430-440.
4. Rizk B, Aboulghar M. 1991 Modern management of ovarian hyperstimulation syndrome. Hum Reprod. 6:1082-1087.
5. Editorial. 1991 Ovarian hyperstimulation syndrome. Lancet. 338:1111-1112.
6. Dourron NE, Williams DB. 1996 Prevention and treatment of ovarian hyperstimulation syndrome. Sem Reprod Endocrinol. 14:355-365.
7. Navot D, Bergh PA, Laufer N. 1992 Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 58:249-61.
8. Schrier RW, Briner VA. 1991 Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol. 77:632-639.
9. Magness RR, Rosenfeld CR. 1989 Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol. 256:E536-E542.
10. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. 1992 Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA. 89:11259-11263.
11. Mügge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. 1993 Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res. 27:1939-1942.
12. Hayashi T, Yamada K, Esaki T, et al. 1995 Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 214:847-855.
13. Herrington DM, Braden GA, Williams JK, Morgan TM. 1994 Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 73:951-952.
14. Ylikorkala O, Orpana A, Puolakka J, Pyörälä T, Viinikka L. 1995 Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab. 80:3384-3387.
15. Gura T. 1995 Estrogen: key player in heart disease among women. Science. 269:771-773.
16. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. 1995 Effects of estrogen replacement therapy on peripheral vasomotor function in post-menopausal women. Am J Cardiol. 75:264-268.
17. Cicinelli E, Ignarro LJ, Lograno M, Galantino P, Balzano G, Schonauer LM. 1996 Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle. Fertil Steril. 66:1036-1038.
18. Pinto S, Virdis A, Ghiadoni L, et al. 1997 Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension. 29:268-73.
19. Sealey JE, Itskovitz-Eldor J, Rubattu S, et al. 1994 Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 79:258-264.
20. Delbaere A, Bergmann PJM, Gervy-Decoster C, et al. 1997 Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril. 67:1038-1045.
21. Speroff L, Glass RH, Kase NG. 1994 Clinical gynecologic endocrinology and infertility, 5th ed. Baltimore: Williams & Wilkins; 183-230.
22. Balasch J, Arroyo V, Fábregues F, et al. 1994 Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome. Ann Intern Med. 121:27-33.
23. Ros J, Jiménez W, Lamas S, et al. 1995 Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology. 21:554-560.
24. Guevara M, Ginés P, Jiménez W, et al. 1998 Increased circulating levels of adrenomedullin in patients with cirrhosis. Relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 114:336-343.
25. Misko PT, Schilling RJ, Salvemini D, Moore WM, Currie MG. 1993 A Fluorometric Assay for the measurement of nitrite in biological samples. Ann Biochem. 214:11-16.
26. Balasch J, Arroyo V, Carmona F, et al. 1991 Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation. Fertil Steril. 56:1077-83.
27. Balasch J, Arroyo V, Fábregues F, Jiménez W, Saló J, Vanrell JA. 1995 Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome. Fertil Steril. 64:65-68.
28. Schrier RW. 1990 Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med. 113:155-159.
29. Navot D, Bergh PA, Laufer N. 1996 The ovarian hyperstimulation syndrome. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven; 2:2215-2232.
30. August P, Mueller FB, Sealey JE, Edersheim TG. 1995 Role of renin-angiotensin system in blood pressure regulation in pregnancy. Lancet. 345:896-897.
31. Pellicer A, De los Santos MJ, Remohí J. 1992 Simultaneous induction of multiple follicular development with gonadotropins and steroid replacement for in-vitro fertilization. Hum Reprod. 7:606-607.
32. Meirow D, Schenker JG, Rosler A. 1996 Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17a-hydroxylase, 17,20-lyase deficiency: what is the role of oestrogens? Hum Reprod. 11:2119-2121.
33. Kitamura K, Kangawa K, Kawamoto M, et al. 1993 Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Common. 192:553-560.
34. Richards AM, Nicholls MG, Lewis L, Lainchbury JG. 1996 Adrenomedullin. Clin Sci. 91:3-16.
35. Scell DA, Van RC, Samson WK. 1996 Adrenomedullin: a newly discovered hormone controlling fluid and electrolyte homeostasis. Trends Endocrinol Metab. 7:7-13.
36. Matsunaga K, Iwasaki T, Yonetani Y, et al. 1996 Nitric oxide-dependent hypotensive effects of adrenomedullin in rats. Drug Develop Res. 37:55-60.